In the United States, consumers are increasingly turning to social media to obtain information about pharmaceutical products and devices, to research medical conditions, and obtain information about potential treatments, available...Read more
Japan is a promising market for companies, in-spite of the pressures posed by drug prices, competition and patents. The reason may be the large growth of pharmaceuticals, an aging population,...Read more
Marianne Slivkova
Senior Corporate Counsel, Acorda Therapeutics, USA
Marianne Slivkova is Director, Legal, Commercial at Acorda Therapeutics. She is primarily responsible for providing legal advice on legal risk, interpretation of FDA advertising regulations, PDMA, healthcare fraud and abuse, product liability, privacy, antitrust statutes and regulations, as well as other federal and state laws, and company policies and procedures to U.S. marketing, sales and medical management, as well as advising on ex-US issues. Prior to joining Acorda, Ms. Slivkova was Senior Corporate Counsel at BMS, and during 2012, she served as the interim head of BMS’s Japanese legal department in Tokyo. Before becoming an in-house attorney, Ms. Slivkova was a Senior Litigation Associate at Moses & Singer in New York City, and at Dewey Ballantine LLP. Ms. Slivkova holds a Master’s of Public Health from the Harvard School of Public Health, a Juris Doctor degree from New York University School of Law, and a Bachelor’s Degree from Columbia College, Columbia University.
